From October 20 to 22, 2026, the 12th Russia International Medical Diagnostics Exhibition (RDS) came to a successful conclusion at CROCUS EXPO in Moscow.
As an established enterprise in the in vitro diagnostics (IVD) industry, Wuhan LIFE ORIGIN unveiled a portfolio of POCT diagnostic reagents and full-scenario solutions at Booth Д8, Hall 8. Over the three-day event, we engaged in in-depth exchanges with clinical experts and distributors from Russia and CIS (Commonwealth of Independent States) countries.
I On-site Highlights: Point-of-Care Testing Solutions Draw Strong Interest
LIFE ORIGIN’s booth enjoyed sustained high foot traffic. As captured on site, numerous overseas visitors stopped by our product display wall to hold in-depth discussions with the LIFE ORIGIN team.
Among the exhibits, on-site nutritional health management and female hormone product lines emerged as the highlights of the exhibition. Addressing Russia’s vast territory and uneven distribution of medical resources in some regions, LIFE ORIGIN’s rapid diagnostic solutions precisely meet the local market’s demand for speed, convenience and high accuracy. Through detailed on-site presentations and demonstrations, our team fully demonstrated to clients how to deliver efficient and accurate point-of-care testing across various scenarios.
II Robust Product Portfolio: IVD Solutions Covering Multiple Clinical Scenarios
LIFE ORIGIN systematically showcased its IVD reagent matrix covering multiple fields, precisely catering to the diversified demands of the local market:
- ✓ Endocrine & Chronic Disease Management: TSH (Thyroid-Stimulating Hormone) and HbA1c (Glycated Hemoglobin A1c) assays, providing reliable support for the management of prevalent thyroid disorders and diabetes.
- ✓ Gastric Health & Infection Screening: Hp (Helicobacter pylori) test, facilitating early screening of digestive system diseases.
- ✓ Reproductive Medicine & Women’s Health: PROG/E2 (Progesterone/Estradiol) assays, offering precise reference for clinical prenatal care and endocrine intervention.
- ✓ Bone Metabolism & Nutritional Screening: Core items including 25-OH-VD (25-Hydroxyvitamin D).
Our extensive and high-quality reagent menu not only reflects LIFE ORIGIN’s solid technological foundation, but also provides more suitable testing options for the local market.
III In-depth Dialogues: Empowering the Local Market and Accelerating Global Layout
At this year’s Russia RDS Expo, LIFE ORIGIN acted not only as an exhibitor of products, but also as a bridge for medical and health industry exchanges between China and Russia.
Through intensive communications with local IVD distributors and frontline clinical experts, we have keenly identified the Russian market’s urgent demand for domestically manufactured diagnostic solutions featuring cost-effectiveness, stable supply chains and solid technical capabilities. Backed by a sound quality system, strong R&D pipeline and flexible cooperation models, LIFE ORIGIN has gained high recognition from multiple parties, laying a solid foundation for our market expansion across Eurasia.
IV The Exhibition Concludes, but Our Journey Continues
The three-day Moscow trip has come to a successful close. LIFE ORIGIN sincerely thanks every industry peer who visited Booth Д8. Your professional discussions and enthusiasm for cooperation have endowed this exhibition with extraordinary significance.
Though the exhibition has ended, LIFE ORIGIN will never stop pursuing cutting-edge technologies and serving global customers. If you did not have the chance for in-depth communication during the exhibition, or if you have further needs for technical discussions and business cooperation regarding our full range of IVD products, please feel free to contact us anytime.
See you at our next stop!
Post time: Oct-29-2026